Advertisement
Elon Musk’s start-up Neuralink has obtained approval from the US Food and Drug Administration for its first in-human clinical study. The aim of Neuralink is to enable human brains to communicate directly with computers.
According to Elon Musk, the company is working hard to get ready for their first human implant and they are taking all steps to ensure that it will work well before implanting a device in a human.
Earlier, product prototypes, the size of a coin, were implanted in the skulls of monkeys. At the Neuralink presentation, the company showed many monkeys playing basic video games or moving a cursor on a screen through the Neuralink implant.
Musk stated that the implant has the potential to treat neurological diseases and to restore vision and mobility to people who had lost such abilities.
Advertisement
